Simplex Trading’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,000
Closed -$6K 10308
2023
Q1
$6K Sell
6,000
-3,100
-34% -$5.67K ﹤0.01% 7983
2022
Q4
$24K Buy
9,100
+1,900
+26% +$5.01K ﹤0.01% 6710
2022
Q3
$20K Buy
7,200
+3,500
+95% +$14.9K ﹤0.01% 7551
2022
Q2
$18K Sell
3,700
-2,000
-35% -$10.5K ﹤0.01% 7743
2022
Q1
$40K Buy
5,700
+4,700
+470% +$38.9K ﹤0.01% 7454
2021
Q4
$18K Sell
1,000
-10,200
-91% -$220K ﹤0.01% 8516
2021
Q3
$528K Hold
11,200
﹤0.01% 4030
2021
Q2
$501K Buy
11,200
+11,073
+8,719% +$513K ﹤0.01% 4172
2021
Q1
$637K Buy
127
+101
+388% +$6.89K ﹤0.01% 3010
2020
Q4
$232K Buy
+26
New +$2.19K ﹤0.01% 4403

Simplex Trading's CELL Position: Q4 2022 in Review

Simplex Trading sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 5,823 shares — an estimated $15.3K sold.

Simplex Trading first reported a position in CELL in Q4 2021 and held it in 4 quarters. The position peaked at $121K in Q2 2022. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

  • Simplex Trading reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 5,823 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $15.3K.
  • Simplex Trading first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Simplex Trading's PhenomeX Inc. Common Stock position peaked at $121K in Q2 2022.
  • 117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.